Table 1.
Open in new tab

Baseline Characteristics of Main Study and Substudy Population

Characteristic Main StudySubstudy
Overall (n=93) Visbiome ES (n=47) Placebo (n=46) Overall (n=29) Visbiome ES (n=14) Placebo (n=15)
Age, y51
(45, 56)		51
(47, 56)		52
(42, 56)		50
(44, 56)		50
(45, 56)		50
(42, 56)
Female sex13 (14)7 (15)6 (13)3 (10)3 (21)0 (0)
Race
White Black/African American50 (55)
38 (42)		24 (53)
21 (47)		26 (57)
17 (37)		13 (45)
15 (52)		6 (43)
8 (57)		7 (47)
7 (47)
Hispanic ethnicity19
(20)		10
(21)		9
(20)		3
(10)		2
(14)		1
(7)
Body mass index, kg/m227
(24, 31)		27
(25, 31)		26
(24, 30)		27
(24, 29)		27
(26, 29)		26
(24, 28)
Current smoker19
(21)		9
(19)		10
(23)		8
(28)		5
(36)		3
(20)
Current ethanol use60
(66)		29
(62)		31
(70)		20
(69)		10
(71)		10
(67)
CD4 count, c/mm3712 (542, 893)702 (483, 866)715 (546, 897)718 (601, 925)790 (601, 951)712 (583, 897)
HIV RNA <40 copies/mL92
(99)		47
(100)		45
(98)		29
(100)		14
(100)		15
(100)
Characteristic Main StudySubstudy
Overall (n=93) Visbiome ES (n=47) Placebo (n=46) Overall (n=29) Visbiome ES (n=14) Placebo (n=15)
Age, y51
(45, 56)		51
(47, 56)		52
(42, 56)		50
(44, 56)		50
(45, 56)		50
(42, 56)
Female sex13 (14)7 (15)6 (13)3 (10)3 (21)0 (0)
Race
White Black/African American50 (55)
38 (42)		24 (53)
21 (47)		26 (57)
17 (37)		13 (45)
15 (52)		6 (43)
8 (57)		7 (47)
7 (47)
Hispanic ethnicity19
(20)		10
(21)		9
(20)		3
(10)		2
(14)		1
(7)
Body mass index, kg/m227
(24, 31)		27
(25, 31)		26
(24, 30)		27
(24, 29)		27
(26, 29)		26
(24, 28)
Current smoker19
(21)		9
(19)		10
(23)		8
(28)		5
(36)		3
(20)
Current ethanol use60
(66)		29
(62)		31
(70)		20
(69)		10
(71)		10
(67)
CD4 count, c/mm3712 (542, 893)702 (483, 866)715 (546, 897)718 (601, 925)790 (601, 951)712 (583, 897)
HIV RNA <40 copies/mL92
(99)		47
(100)		45
(98)		29
(100)		14
(100)		15
(100)

Data are presented as median value (Q1, Q3) or No. (%).

Abbreviation: ES, Extra Strength.

Table 1.
Open in new tab

Baseline Characteristics of Main Study and Substudy Population

Characteristic Main StudySubstudy
Overall (n=93) Visbiome ES (n=47) Placebo (n=46) Overall (n=29) Visbiome ES (n=14) Placebo (n=15)
Age, y51
(45, 56)		51
(47, 56)		52
(42, 56)		50
(44, 56)		50
(45, 56)		50
(42, 56)
Female sex13 (14)7 (15)6 (13)3 (10)3 (21)0 (0)
Race
White Black/African American50 (55)
38 (42)		24 (53)
21 (47)		26 (57)
17 (37)		13 (45)
15 (52)		6 (43)
8 (57)		7 (47)
7 (47)
Hispanic ethnicity19
(20)		10
(21)		9
(20)		3
(10)		2
(14)		1
(7)
Body mass index, kg/m227
(24, 31)		27
(25, 31)		26
(24, 30)		27
(24, 29)		27
(26, 29)		26
(24, 28)
Current smoker19
(21)		9
(19)		10
(23)		8
(28)		5
(36)		3
(20)
Current ethanol use60
(66)		29
(62)		31
(70)		20
(69)		10
(71)		10
(67)
CD4 count, c/mm3712 (542, 893)702 (483, 866)715 (546, 897)718 (601, 925)790 (601, 951)712 (583, 897)
HIV RNA <40 copies/mL92
(99)		47
(100)		45
(98)		29
(100)		14
(100)		15
(100)
Characteristic Main StudySubstudy
Overall (n=93) Visbiome ES (n=47) Placebo (n=46) Overall (n=29) Visbiome ES (n=14) Placebo (n=15)
Age, y51
(45, 56)		51
(47, 56)		52
(42, 56)		50
(44, 56)		50
(45, 56)		50
(42, 56)
Female sex13 (14)7 (15)6 (13)3 (10)3 (21)0 (0)
Race
White Black/African American50 (55)
38 (42)		24 (53)
21 (47)		26 (57)
17 (37)		13 (45)
15 (52)		6 (43)
8 (57)		7 (47)
7 (47)
Hispanic ethnicity19
(20)		10
(21)		9
(20)		3
(10)		2
(14)		1
(7)
Body mass index, kg/m227
(24, 31)		27
(25, 31)		26
(24, 30)		27
(24, 29)		27
(26, 29)		26
(24, 28)
Current smoker19
(21)		9
(19)		10
(23)		8
(28)		5
(36)		3
(20)
Current ethanol use60
(66)		29
(62)		31
(70)		20
(69)		10
(71)		10
(67)
CD4 count, c/mm3712 (542, 893)702 (483, 866)715 (546, 897)718 (601, 925)790 (601, 951)712 (583, 897)
HIV RNA <40 copies/mL92
(99)		47
(100)		45
(98)		29
(100)		14
(100)		15
(100)

Data are presented as median value (Q1, Q3) or No. (%).

Abbreviation: ES, Extra Strength.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close